CRO ClinicalRM has signed a deal with the Ohio Clinical Trials Collaborative to join forces in a co-marketing arrangement, looking to expand its role in the state's drug and device development scene.
The collaborative is designed to bolster Ohio's place in the market for clinical trials, uniting the medical centers at Case Western Reserve University, Ohio State University and the University of Cincinnati. OCTC works to streamline contracting, budgeting and enrollment for studies in the state, and, under the new agreement, ClinicalRM is stepping up to offer its development services to the collaborative's clients.
ClinicalRM operates from preclinical study to Phase IV trials, and teaming up with OCTC will help it expand its client roster while supporting the effort to improve Ohio's clinical research stature, Vice President Alan Braverman said.
"ClinicalRM is pleased to align forces with the OCTC," Braverman said in a statement. "Expedited access to Ohio's premier medical institutions will shorten the time to start a new multi-site clinical trial as well as assure timely patient enrollment for our clients."
The CRO has been around for 20 years, employing 350 scientists, investigators and staff.
- read the statement